Table 4.
Adverse Outcome | n2 | % |
---|---|---|
Specific birth defects | 175 | 55.7 |
Heart defects | 160 | 51.0 |
Craniofacial defects | 100 | 32.0 |
Neural tube defects | 67 | 21.3 |
Abdominal defects | 53 | 17.0 |
Club feet | 53 | 17.0 |
Lung defects | 51 | 16.2 |
Limb defects | 27 | 8.6 |
Anal defects | 12 | 3.8 |
Muscular/skeletal defects | 6 | 1.9 |
Brain defects | 6 | 1.9 |
Genital defects | 4 | 1.3 |
Chromosomal abnormalities | 2 | 0.6 |
Nonspecific birth defects3 | 56 | 17.8 |
PPHN | 83 | 26.4 |
Behavioral/developmental disabilities4 | 35 | 11.2 |
Non-birth defect complications in the infant | 21 | 6.7 |
Neonatal abstinence syndrome | 12 | 3.8 |
Death | 5 | 1.6 |
Outcomes related to the mother | 28 | 8.9 |
Birth related complications5 | 19 | 6.1 |
None | 7 | 2.2 |
Missing | 53 | 16.9 |
Notes: PPHN=Persistent pulmonary hypertension of the newborn
All groups are indicators (i.e., videos could report more than one effect for every medication discussed and are therefore counted in each group indicated); exception to this is nonspecific birth defects when a birth defect by location was also given (see note below).
Some videos discussed more than one effect (i.e., they might be represent more than once in this column), therefore, the sum of videos within each effect type will not equal the number of videos for each effect type.
Only includes videos in which no specific birth defects were mentioned.
Includes autism, developmental disabilities not otherwise specified, and behavioral problems not otherwise specified.
Includes preterm birth, miscarriage, low birth weight, and general birth complications.